Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $103,000.00 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 4,000 shares of the company’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $25.75, for a total value of $103,000.00. Following the completion of the transaction, the insider directly owned 6,897,764 shares in the company, valued at $177,617,423. This trade represents a 0.06% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.28, for a total value of $437,040.00.
• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.74, for a total transaction of $403,262.00.

OrthoPediatrics Stock Up 1.4%

Shares of NASDAQ:KIDS opened at $23.65 on Friday. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. The stock has a market cap of $617.50 million, a P/E ratio of -14.08 and a beta of 0.98. The business’s 50 day moving average is $21.41 and its 200 day moving average is $18.66. OrthoPediatrics Corp. has a 52-week low of $14.42 and a 52-week high of $26.74.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The company had revenue of $70.51 million during the quarter, compared to analysts’ expectations of $68.21 million. Sell-side analysts predict that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently weighed in on KIDS. BTIG Research increased their price target on shares of OrthoPediatrics from $24.00 to $29.00 and gave the stock a “buy” rating in a report on Thursday, August 20th. Truist Financial set a $22.00 target price on shares of OrthoPediatrics in a report on Wednesday, August 5th. Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Needham & Company LLC lifted their price objective on OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Nine investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $26.44.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of KIDS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock valued at $246,000 after purchasing an additional 645 shares in the last quarter. Millennium Management LLC boosted its position in OrthoPediatrics by 55.3% during the first quarter. Millennium Management LLC now owns 656,578 shares of the company’s stock worth $16,172,000 after purchasing an additional 233,873 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in OrthoPediatrics by 112.3% in the first quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock valued at $4,937,000 after purchasing an additional 106,041 shares during the period. Jane Street Group LLC purchased a new stake in shares of OrthoPediatrics in the first quarter valued at approximately $389,000. Finally, American Century Companies Inc. increased its position in shares of OrthoPediatrics by 12.5% in the second quarter. American Century Companies Inc. now owns 34,486 shares of the company’s stock valued at $741,000 after buying an additional 3,828 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.